News & Updates
Filter by Specialty:

Is vitiligo as side effect a good sign for cancer patients on immunotherapy?
03 Apr 2025
byJairia Dela Cruz
Vitiligo occurs as a cutaneous immune-related adverse event during immune checkpoint inhibitor (ICI) therapy in most melanoma and nonmelanoma cancer patients with partial or complete response to treatment, according to a systematic review.